Here are four points:
1. The meeting is slated to take place on April 20.
2. The implant is intended for the treatment of osteoarthritis at the base of the big toe.
3. The FDA recently completed a five-day inspection of Cartiva’s Alpharetta, Ga., facility and reported no issues.
4. Cartiva is a developer of products for the treatment of cartilage injuries, osteoarthritis and other musculoskeletal conditions.
More articles on devices:
Smith & Nephew, Zimmer Biomet, Medovex & more: 20 key notes
Global non-fusion spinal device market to grow: 3 points
Medtech sells 2 ROSA Brain robots in US: 3 quick notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
